Transforming Women's Health.

Dedicated to improving the lives of women, starting with Ovarian Cancer

Latest News & Events

View More

  • Aspira Women’s Health Inc. to Report Second Quarter 2021 Financial Results on August 12

    Press Release

    Read More
  • Aspira Women’s Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines

    Press Release

    Read More
  • Aspira Women’s Health Releases Analytical and Initial Clinical Validation Performance for OVASight at ASCO 2021

    Press Release

    Read More

The Ovarian Cancer story has to change, Aspira is passionately dedicated to making a difference.

We are committed to solving women's health issues for all ethnicities, stages, and ages. Our data-driven approach delivers solutions that help women take control of their gynecologic health and empowers providers to deliver optimal care. We are using our 10+ years of experience in ovarian cancer risk assessment to develop a cutting-edge portfolio of pelvic mass products.

Learn About Our Research

Our Products


  • Relentless pursuit of products to improve ovarian cancer detection and care. Learn about why OVA1plus is the best way to assess risk prior to surgery.

    Learn More
  • Hereditary Gynecologic cancer detection and carrier screening. Learn about your inherited risk through genetic testing.

    Learn More
  • Aspira Synergy is a technology transfer platform that enables our customers to bring in-house the ability to perform specialty testing. Learn more about how to bring both OVA1plus and state-of-the-art genetic testing into your laboratory.

    Learn More

Testimonials


  • OVA1 is using five different biomarkers compared to other tests, and is much more sensitive especially for detection of early stage disease.

    - Kathy Anderson MD, FACOG, JD, ABAARM
  • OVA1 is great in that it can help to avoid second procedures on patients and second operations which can be associated with higher morbidity.

    - Jonathan Black MD, MPH
  • OVA1®plus has added to our armamentarium as physicians by decreasing the false positive rate up to 50%

    - Howard C. Mandel MD, FACOG

Careers At Aspira Women's Health

Aspira is dedicated to transforming women's health with a unique approach to ovarian cancer risk assessment and detection.


We are always looking for talented, driven individuals to join our team of innovators. We are a small company with some very big ideas.

Are you ready to help us inspire change in women's health? Then we want to hear from you!

Join Us!